Back to Browse Journals » Substance Abuse and Rehabilitation » Volume 3 » Supplement 1

Meeting the substance abuse treatment needs of lesbian, bisexual and transgender women: implications from research to practice

Authors Stevens S

Published Date February 2012 Volume 2012:3(Supplement 1) Pages 27—36

DOI http://dx.doi.org/10.2147/SAR.S26430

Received 22 September 2011, Accepted 5 November 2011, Published 1 February 2012

Sally Stevens

Southwest Institute for Research on Women (SIROW) and Department of Gender and Women’s Studies (GWS), University of Arizona, Tucson, AZ, USA

Abstract: Research on the incidence, etiology and substance abuse treatment needs of lesbian, bisexual and transgender (LBT) women is limited. Most research indicates higher levels of alcohol and drug abuse among these populations compared to their heterosexual counterparts, with recent research indicating that substance abuse is a particular concern for transgender individuals and an increasing problem among younger LBT individuals. Risk factors and reasons for substance abuse among sexual minority women are similar to those of heterosexual women, yet are substantially complicated by issues of family rejection and lack of social support, stigma and minority stress, as well as abuse and harassment. Historically, substance abuse prevention, early intervention, and clinical treatment programs were designed to meet the needs of the sexual majority population with relatively few programs designed to incorporate the specific needs of sexual minorities. This article reviews findings from previous studies and utilizes new data collected from community-based and residential substance abuse treatment programs to (1) examine issues relevant to LBT women and substance use, and (2) make recommendations for tailoring substance abuse treatment programs to meet the needs of these populations.

Keywords: lesbian, bisexual, transgender, substance abuse, family rejection, social support, stigma, minority stress, abuse, harassment

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Biologic targeting in the treatment of inflammatory bowel diseases [Retraction]

Bosani M, Ardizzone S, Porro GB

Biologics: Targets and Therapy 2014, 8:39-40

Published Date: 31 January 2014

Prevalence of dementia in Al-Quseir city, Red Sea Governorate, Egypt [Corrigendum]

El Tallawy HN, Farghly WM, Badry R, Rageh TA, Shehata GA, Hakeem M NA, El Hamed MA, Sayd MAM, Hamed Y, Kandil MR

Clinical Interventions in Aging 2014, 9:129-130

Published Date: 10 January 2014

The Treatment Effectiveness Assessment (TEA)

Ling W, Farabee D, Liepa D, Wu LT

Substance Abuse and Rehabilitation 2013, 4:73-74

Published Date: 24 September 2013

Targeting nanomaterials: future drugs for cancer chemotherapy

Zhang Y, Chen T

International Journal of Nanomedicine 2012, 7:5283-5286

Published Date: 10 October 2012

GOLD and the fixed ratio

Vestbo J

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:663-665

Published Date: 25 September 2012

Nanodrugs: optimism for emerging trend of multidrug resistance

Khan AU

International Journal of Nanomedicine 2012, 7:4323-4324

Published Date: 6 August 2012

Measurement complexity of adherence to medication

Galato D, Schuelter-Trevisol F, Piovezan AP

Therapeutics and Clinical Risk Management 2012, 8:169-171

Published Date: 2 April 2012

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta, Suzanne Oparil

Vascular Health and Risk Management 2009, 5:453-463

Published Date: 19 May 2009